Pfizer Sales Hit by Stronger Dollar

Pfizer said a strong U.S. dollar and recent drug-patent losses contributed to a 52% drop in net income in the fourth quarter and would depress results this year. It also settled a securities lawsuit.



from WSJ.com: US Business http://ift.tt/1JW1dMT

via IFTTT